tiprankstipranks
Trending News
More News >
Viemed Healthcare US (VMD)
:VMD
US Market
Advertisement

Viemed Healthcare (VMD) Ratios

Compare
159 Followers

Viemed Healthcare Ratios

VMD's free cash flow for Q2 2025 was $0.58. For the 2025 fiscal year, VMD's free cash flow was decreased by $ and operating cash flow was $0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.48 1.19 2.11 2.66 2.05
Quick Ratio
1.37 1.05 1.92 2.52 1.95
Cash Ratio
0.54 0.40 0.90 1.59 1.35
Solvency Ratio
0.94 0.78 1.10 0.88 1.33
Operating Cash Flow Ratio
1.15 1.41 1.47 1.26 1.53
Short-Term Operating Cash Flow Coverage
24.76 42.18 56.06 11.57 7.67
Net Current Asset Value
$ 12.31M$ -2.63M$ 19.79M$ 24.17M$ 16.31M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.07 <0.01 0.06 0.10
Debt-to-Equity Ratio
0.05 0.09 <0.01 0.07 0.14
Debt-to-Capital Ratio
0.05 0.08 <0.01 0.06 0.12
Long-Term Debt-to-Capital Ratio
0.02 0.05 0.00 0.04 0.07
Financial Leverage Ratio
1.32 1.36 1.21 1.24 1.38
Debt Service Coverage Ratio
17.09 21.76 30.72 8.16 7.02
Interest Coverage Ratio
29.92 33.80 41.89 36.42 52.61
Debt to Market Cap
0.02 0.02 <0.01 0.03 0.03
Interest Debt Per Share
0.19 0.28 0.02 0.17 0.30
Net Debt to EBITDA
-0.28 -0.07 -0.68 -1.00 -0.65
Profitability Margins
Gross Profit Margin
58.19%61.63%60.99%62.71%61.01%
EBIT Margin
8.76%8.10%6.05%8.99%15.96%
EBITDA Margin
19.67%20.06%17.31%18.66%23.25%
Operating Profit Margin
8.48%7.83%5.94%9.89%20.40%
Pretax Profit Margin
8.48%7.86%6.48%10.68%20.08%
Net Profit Margin
5.80%5.60%4.48%7.80%24.01%
Continuous Operations Profit Margin
5.93%5.60%4.48%7.80%24.01%
Net Income Per EBT
68.41%71.18%69.21%72.99%119.60%
EBT Per EBIT
99.98%100.43%108.94%107.97%98.44%
Return on Assets (ROA)
7.57%6.61%5.32%7.74%28.01%
Return on Equity (ROE)
10.53%8.99%6.41%9.62%38.60%
Return on Capital Employed (ROCE)
13.87%11.67%8.40%11.56%29.91%
Return on Invested Capital (ROIC)
9.59%8.17%5.76%8.24%33.07%
Return on Tangible Assets
9.27%8.22%5.32%7.74%28.01%
Earnings Yield
4.83%3.40%2.13%4.43%10.49%
Efficiency Ratios
Receivables Turnover
9.07 9.92 9.01 7.95 10.61
Payables Turnover
12.20 9.48 20.43 13.48 24.43
Inventory Turnover
23.29 15.17 15.15 17.77 22.16
Fixed Asset Turnover
2.92 2.38 2.03 1.86 2.39
Asset Turnover
1.30 1.18 1.19 0.99 1.17
Working Capital Turnover Ratio
15.22 13.49 5.51 4.36 10.08
Cash Conversion Cycle
25.99 22.34 46.73 39.35 35.92
Days of Sales Outstanding
40.23 36.80 40.50 45.88 34.39
Days of Inventory Outstanding
15.67 24.05 24.09 20.54 16.47
Days of Payables Outstanding
29.91 38.51 17.86 27.08 14.94
Operating Cycle
55.90 60.85 64.59 66.43 50.86
Cash Flow Ratios
Operating Cash Flow Per Share
1.08 1.18 0.72 0.57 0.91
Free Cash Flow Per Share
-0.09 0.50 0.13 0.07 0.57
CapEx Per Share
1.18 0.68 0.59 0.50 0.34
Free Cash Flow to Operating Cash Flow
-0.08 0.42 0.17 0.12 0.63
Dividend Paid and CapEx Coverage Ratio
0.92 1.73 1.21 1.14 2.69
Capital Expenditure Coverage Ratio
0.92 1.73 1.21 1.14 2.69
Operating Cash Flow Coverage Ratio
6.22 4.38 39.98 3.45 3.15
Operating Cash Flow to Sales Ratio
0.18 0.25 0.20 0.19 0.27
Free Cash Flow Yield
-1.27%6.35%1.66%1.33%7.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
20.72 29.39 46.97 22.59 9.54
Price-to-Sales (P/S) Ratio
1.18 1.65 2.10 1.76 2.29
Price-to-Book (P/B) Ratio
2.07 2.64 3.01 2.17 3.68
Price-to-Free Cash Flow (P/FCF) Ratio
-78.91 15.75 60.25 74.93 13.63
Price-to-Operating Cash Flow Ratio
6.76 6.66 10.53 9.16 8.56
Price-to-Earnings Growth (PEG) Ratio
1.66 0.37 -1.35 -0.31 0.03
Price-to-Fair Value
2.07 2.64 3.01 2.17 3.68
Enterprise Value Multiple
5.72 8.13 11.49 8.44 9.20
Enterprise Value
271.17M 298.56M 276.01M 184.25M 280.80M
EV to EBITDA
5.72 8.13 11.49 8.44 9.20
EV to Sales
1.13 1.63 1.99 1.57 2.14
EV to Free Cash Flow
-75.26 15.62 56.91 66.98 12.73
EV to Operating Cash Flow
6.33 6.60 9.95 8.19 8.00
Tangible Book Value Per Share
2.73 2.18 2.51 2.40 2.11
Shareholders’ Equity Per Share
3.54 2.97 2.51 2.40 2.11
Tax and Other Ratios
Effective Tax Rate
0.30 0.29 0.31 0.27 -0.20
Revenue Per Share
6.10 4.77 3.59 2.96 3.39
Net Income Per Share
0.35 0.27 0.16 0.23 0.81
Tax Burden
0.68 0.71 0.69 0.73 1.20
Interest Burden
0.97 0.97 1.07 1.19 1.26
Research & Development to Revenue
0.01 0.02 0.02 0.02 <0.01
SG&A to Revenue
0.24 0.51 0.53 0.51 0.44
Stock-Based Compensation to Revenue
0.03 0.03 0.04 0.04 0.04
Income Quality
3.04 4.41 4.46 2.46 1.11
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis